L-DOPA increases slow-wave sleep duration and selectively modulates memory persistence in older adults
CORRECTION article
Corrigendum: L-DOPA Increases Slow-Wave Sleep Duration and Selectively Modulates Memory Persistence in Older AdultsL-DOPA increases slow-wave sleep duration and selectively modulates memory persistence in older adults
Provisionally accepted- 1 Institute of Clinical Neurosciences, Department of Translational Health Sciences, Bristol Medical School, Faculty of Health Sciences, University of Bristol, Bristol, England, United Kingdom
- 2 Digital Health, Faculty of Engineering, University of Bristol, Bristol, England, Bristol, England, United Kingdom
- 3 University of Bristol, Bristol, United Kingdom
- 4 North Bristol NHS Trust, Bristol, England, United Kingdom
- 5 Neurosurgical Clinic, Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany
- 6 Production Pharmacy, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Trust, Bristol, United Kingdom, bristol, United Kingdom
- 7 Department of Electrical and Electronic Engineering, School of Computer Science, Electrical and Electronic Engineering and Engineering Maths, Faculty of Engineering, University of Bristol, Bristol, England, United Kingdom
- 8 Experimental Psychology, University of Bristol, Bristol, United Kingdom
- 9 School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, Bristol, England, United Kingdom
- 10 Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, England, United Kingdom
- 11 Trinity College Institute for Neuroscience, School of Psychology, Trinity College Dublin, Dublin, County Dublin, Ireland
Keywords: Sleep, Memory, Dopamine, Ageing, slow wave sleep, NREM, Levodopa, Learning
Received: 09 Aug 2024; Accepted: 12 Aug 2024.
Copyright: © 2024 Isotalus, Carr, Blackman, Averill, Radtke, Selwood, Williams, Ford, McCullagh, McErlane, O'Donnell, Durant, Bartsch, Jones, Muñoz-Neira, Wearn, Grogan and Coulthard. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Hanna K. Isotalus, Institute of Clinical Neurosciences, Department of Translational Health Sciences, Bristol Medical School, Faculty of Health Sciences, University of Bristol, Bristol, BS10 5NB, England, United Kingdom
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.